MONTEREY BIO ACQUISITION COR - COM (MTRY)

CUSIP: 61240F108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
11,017,417
Share change
+1,250,593
Total reported value
$109,735,000
Price per share
$9.96
Number of holders
41
Value change
+$12,473,224
Number of buys
16
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MONTEREY BIO ACQUISITION COR - COM (MTRY) as of Q1 2022

As of 31 Mar 2022, MONTEREY BIO ACQUISITION COR - COM (MTRY) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,017,417 shares. The largest 10 holders included Saba Capital Management, L.P., Karpus Management, Inc., Periscope Capital Inc., MMCAP International Inc. SPC, BOOTHBAY FUND MANAGEMENT, LLC, ATW SPAC MANAGEMENT LLC, D. E. Shaw & Co., Inc., Weiss Asset Management LP, Murchinson Ltd., and Shaolin Capital Management LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.